Home -> Law Blog Directory -> Patent Law Blogs -> IP ADR Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IP ADR BlogWhat if a patent settlement agreement risks being illegal?
By Eric Van Ginkel
Several weeks ago, I came across an exciting article by Frances Murphy and Francesco Liberatore of Jones Day's London office, that I wanted to blog about, but did not get around to. By pure coincidence, I looked at it again today, and concluded I still want to blog about it!
Why?
Because I believe it is an important subject that every IP mediator and every mediation participant needs to be aware of!
The article alerts us to the fact that recently the European Commission began a process of checking whether patent settlements concluded among a number of pharmaceutical companies infringe EU Antitrust laws.
In this particular case, the Commission had sent an information request in January of this year as a follow-up to its inquiry into the pharmaceutical sector. As Frances and Francesco point out, 'The Commission is in particular looking at patent settlements where an originator company pays off a generic competitor in return for delayed market entry of a generic drug (so-called 'reverse payments patent settlements').'
This suggests, the authors write, 'that the Commission may be initiating a program to periodically monitor settlement agreements and could launch infringement proceedings against settlements it finds anticompetitive.'
The authors then go into the details of the antitrust rules regarding reverse payments patent deals, and analyze ho they compare to the law in the United States as it is developing between the FTC and the US courts. For a copy of the article, look here.
What interests me for our IP ADR Blog is how the eternal conflict between the antitrust laws and the 'carve-out' created by patent protection may affect mediation.
Clearly, the parties, and hopefully also the mediator, need to be on the lookout for how patent laws interact with the antitrust laws of the United States and the European Union. Of course, while the mediator should not ever be tempted to give legal advice, it would be entirely within his province to raise the issue as a question as he/she helps the parties as they explore settlement options.
What should the mediator do if the parties agree on a settlement that he knows will violate antitrust laws? What if he only suspects it may violate antitrust laws? I welcome your input!
-EvG
Full post as published by IP ADR Blog on March 31, 2010 (boomark / email).
Prenuptial Agreements
Make an Airtight Prenuptial Agreement
Illegal Immigrant Responsibility and Reform Act of 1996
Explanation of the controversial illegal immigration law
Uniform Pre-marital Agreement Act
Standard Prenuptial Law
MRI Health Risks
alleging gadolinium based contrast agents pose health risks.
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Loan Agreement
Vernalis to pay Endo Pharmaceuticals $7 million settlement.
Merger Agreement Rejected
Finish Line and Genesco reach $175 million settlement in merger dispute.

Qualcomm Agrees To Pay Broadcom $891 Million as Part of Settlement Agreement
Settlement Remorse Fails To Move Court
A Release in a Settlement Agreement is Not Effective Until All Amounts Due are Paid
Red Hat Makes History With Patent Settlement - Compatible with GPLv3








